Exploring the potential of cellular thermal shift assay (CETSA) to study drug resistance during cancer therapy

被引：1
|
作者：
Kunjamma, Lekshmy
Sreekumar, Usha
Lim, Yan Ting
Veerappan, Saranya
Nordlund, Par
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-2045
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2045
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Exploring enzyme-immobilized MOFs and their application potential: biosensing, biocatalysis, targeted drug delivery and cancer therapy
    Prakash, Om
    Verma, Deepika
    Singh, Poonam C.
    JOURNAL OF MATERIALS CHEMISTRY B, 2024, 12 (40) : 10198 - 10214
  • [42] Line probe assay for monitoring drug resistance in hepatitis B virus-infected patients during antiviral therapy
    Stuyver, L
    Van Geyt, C
    De Gendt, S
    Van Reybroeck, G
    Zoulim, F
    Leroux-Roels, G
    Rossau, R
    JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (02) : 702 - 707
  • [43] A Preliminary Study in Search of Potential Peptide Candidates for a Combinational Therapy with Cancer Chemotherapy Drug
    Rothan, Hussin A.
    Ambikabothy, Jamunaa
    Ramasamy, Thamil Selvee
    Rashid, Nurshamimi Nor
    Yusof, Rohana
    INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2019, 25 (01) : 115 - 122
  • [44] Potential drug interactions in cancer therapy: a prevalence study using an advanced screening method
    van Leeuwen, R. W. F.
    Swart, E. L.
    Boven, E.
    Boom, F. A.
    Schuitenmaker, M. G.
    Hugtenburg, J. G.
    ANNALS OF ONCOLOGY, 2011, 22 (10) : 2334 - 2341
  • [45] A Preliminary Study in Search of Potential Peptide Candidates for a Combinational Therapy with Cancer Chemotherapy Drug
    Hussin A. Rothan
    Jamunaa Ambikabothy
    Thamil Selvee Ramasamy
    Nurshamimi Nor Rashid
    Rohana Yusof
    International Journal of Peptide Research and Therapeutics, 2019, 25 : 115 - 122
  • [46] A computational study of combination HIFU-chemotherapy as a potential means of overcoming cancer drug resistance
    Ghasemi, Maryam
    Sivaloganathan, Sivabal
    MATHEMATICAL BIOSCIENCES, 2020, 329
  • [47] Potential drug candidates as P-glycoprotein inhibitors to reverse multidrug resistance in cancer: an in silico drug discovery study
    Ibrahim, Mahmoud A. A.
    Abdeljawaad, Khlood A. A.
    Jaragh-Alhadad, Laila A.
    Oraby, Hesham Farouk
    Atia, Mohamed A. M.
    Alzahrani, Othman R.
    Mekhemer, Gamal A. H.
    Moustafa, Mahmoud F.
    Shawky, Ahmed M.
    Sidhom, Peter A.
    Abdelrahman, Alaa H. M.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (23): : 13977 - 13992
  • [48] Quantitative target engagement of RIPK1 in human whole blood via the cellular thermal shift assay for potential pre-clinical and clinical applications
    Patel, Shitalben
    Karlsson, Marie
    Klahn, Joseph T.
    Gambino, Frank
    Costa, Helena
    McGuire, Kathleen A.
    Baumgartner, Christina K.
    Williams, Jon
    Sandoz, Sarah
    Kath, James E.
    SLAS DISCOVERY, 2024, 29 (02)
  • [49] Cellular Immune Function Assay (ImmuKnow) Values during Treatment of Chronic Gvhd Status with Combined Immunosuppressive Drug and Extracorporeal Photopheresis Therapy
    Matin, Aasiya
    Moraes, Leandro Peterson
    Atwal, Dinesh
    Konda, Manojna
    Pandey, Yadav
    Hiegel, Amy
    Fox, Michele Cottler
    Veeraputhiran, Muthu
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [50] The role of SIRT1 in autophagy and drug resistance: unveiling new targets and potential biomarkers in cancer therapy
    Tang, Yujing
    Ju, Wantao
    Liu, Yanjun
    Deng, Qin
    FRONTIERS IN PHARMACOLOGY, 2024, 15
12345